Deep Dive: How Eli Lilly Became the First $1 Trillion Healthcare Company
The Rundown
00:00
Patent cliff and limited window
Zaid warns that exclusivity will end, generics will erode profits, and Lilly has a finite period to maximize GLP-1 returns.
Play episode from 10:38
Transcript
